Comparative Effectiveness of Enlarged Prostate Treatments in Medicare-eligible Men

home / publications / supplement / 2008-05-vol14-n5suppl

Cost Comparison of Finasteride and Dutasteride for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

Michael Naslund, MD, MBA;Michael T. Eaddy, PharmD, PhD;Eric J. Kruep, PharmD, MS;Susan L. Hogue, PharmD, MPH

ArticleSUPPLEMENT CONTENT

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

Muta M. Issa, MD, MBA;Pei-Jung Lin, PhD;Michael T. Eaddy, PharmD, PhD;Manan B. Shah, PharmD, PhD;E. Anne Davis, PharmD, MS

ArticleSUPPLEMENT CONTENT

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

Thomas C. Fenter, MD;E. Anne Davis, PharmD, MS;Manan B. Shah, PharmD, PhD;Pei-Jung Lin, PhD

ArticleSUPPLEMENT CONTENT

5-Alpha Reductase Inhibitors in Men With an Enlarged Prostate: An Evaluation of Outcomes and Therapeutic Alternatives

Michael Naslund, MD, MBA;Timothy S. Regan, BPharm, RPh, CPh;Christine Ong, PharmD, MBA, BS;Susan L. Hogue, PharmD, MPH

ArticleSUPPLEMENT CONTENT

Participating Faculty

April 30th 2008

ArticleSUPPLEMENT CONTENT

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions